UBS O'Connor’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-259,965	Closed	-$335K	–	452
2023 Q3	$335K	Hold	259,965	–	–	0.01%	410
2023 Q2	$447K	Buy	259,965 +12,808	+5%	+$22K	0.01%	440
2023 Q1	$373K	Buy	+247,157	New	+$373K	0.01%	470